PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Benzethonium→

Benzethonium PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
10172-60-8
Molecular formula
C27H42NO2+
Molecular weight
412.6 g/mol
Drug class
Quaternary ammonium antisepticcationic surfactant
Mechanism of action
Adsorbs to microbial cell membranes and disrupts membrane integrity, leading to leakage of intracellular contents and loss of microbial viability. It is primarily a local antiseptic and is not intended for systemic administration.
Indications / reported uses
  • Topical cleansing and antisepsis of minor skin wounds in authorised OTC preparations
  • Use as an antimicrobial preservative or antiseptic excipient in selected products; exact claims depend on formulation and jurisdiction

Sources: US eCFR — Skin antiseptic drug products · PubChem — Benzethonium chloride · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Benzethonium PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Benzethonium Permitted Daily Exposure (PDE) report (the Benzethonium PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Benzethonium Occupational Exposure Limit (OEL) report (the Benzethonium OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.